THE European Union’s drug watchdog has recommended approval of pharmaceutical giant GSK’s vaccine against the RSV respiratory virus for over-60s, the British firm said today.
There are currently no authorised shots for the common virus, which causes cold-like symptoms in most cases but can be serious or even deadly in vulnerable older people.